SCHEMBL7474966

SCHEMBL7474966

CCNC(=O)N=C(NC(CC(C)C)C(=O)NC1(C#N)CCN(Cc2ccccc2)C1)N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CTSS P25774 13/20 0.52
CTSL P07711 8/20 0.47
CTSB P07858 2/20 0.43
CTSK P43235 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5362103 0.88 CTSS (0.65) CTSSCTSLCTSB
SCHEMBL5362109 0.88 CTSS (0.65) CTSSCTSLCTSB
SCHEMBL7478292 0.87 CTSS (0.53) CTSSCTSLCTSBCTSK
SCHEMBL6107975 0.86 CTSS (0.60) CTSSCTSL
SCHEMBL6105630 0.83 CTSS (0.43) CTSSCTSLCTSK
SCHEMBL5366939 0.82 CTSS (0.52) CTSSCTSLCTSBCTSK
SCHEMBL5366935 0.82 CTSS (0.52) CTSSCTSLCTSBCTSK
SCHEMBL6964964 0.82 CTSS (0.53) CTSSCTSLCTSBCTSK
SCHEMBL5357536 0.81 CTSS (0.66) CTSSCTSLCTSB
SCHEMBL5357539 0.81 CTSS (0.66) CTSSCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed